معرفی
Lisa Fucito is an Associate Professor of Psychiatry at Yale School of Medicine and Director of the Tobacco Treatment Service at Smilow Cancer Hospital. Her work focuses on tobacco and alcohol use disorders, digital health interventions, and lifestyle risk behaviors. She leads NIH-funded studies addressing e-cigarette cessation, sleep-alcohol interactions, and FDA tobacco product regulation. Her research integrates wearable sensors, telehealth, and machine learning to improve clinical care. Key roles include Deputy Editor of Current Addiction Reports, Associate Editor of Biological Psychiatry, and leadership in the NIAAA-funded Center for the Translational Neuroscience of Alcoholism.
- Education: PhD in Psychology (American University, 2008), MA (American University, 2005), BA (Boston College, 1998)
- Research Interests: Digital health interventions, tobacco harm reduction, sleep and addiction comorbidity
- Grants: Over $10M in NIH funding including NCI R01CA296186, NIDA R01DA061285, NIAAA R01AA030136
- Labs: Digital Insights Lab, Center for Nicotine and Tobacco Use Research (CENTURY)
- Awards: Society for Research on Nicotine & Tobacco Young Investigator Award, Yale Distinguished Faculty Award
Her interventions target modifiable risk behaviors through personalized technology, with a focus on vulnerable populations. Current clinical trials include varenicline for e-cigarette cessation and CBT for insomnia as a smoking relapse prevention mechanism.
